Prevention of Adverse Cardiovascular Events Using the 23-Valent Pneumococcal Polysaccharide Vaccine
Shu Ren, David N Dürrheim, Christopher Levi, David Newby et al.
Journal
JAMA Cardiology
Topics
Atherosclerosis and Cardiovascular Diseases
article
Prevention of Adverse Cardiovascular Events Using the 23-Valent Pneumococcal Polysaccharide Vaccine
Shu Ren, David N Dürrheim, Christopher Levi, David Newby, Catherine Anne D’Este, Andrew Tonkin, Derek P. Chew, Amanda Gay Thrift, Mark McEvoy, Walter P. Abhayaratna, Stuart Szwec, Roseanne Peel, John Attia, Philip M. Hansbro, Alexis Hure, Tom Briffa, Ingrid Hopper, Joseph Hung, Jonathan Sturm, Simon Chiu
article en
Abstract
No abstract available for this paper.
Publication Tag
JAMA CardiologyVol. 10(11)
Institutions
The University of Western Australia (AU), John Hunter Hospital (AU), Centenary Institute (AU), Monash Medical Centre (AU), Canberra Hospital (AU), Hunter Medical Research Institute (AU), Sax Institute (AU), Australian Centre for Heart Health (AU), ACT Government (AU), Monash University (AU), University of Newcastle Australia (AU)
Ask Laika to Summarize, Analyze, and Connect papers live on the map.
Summarize Papers & Methodologies
Extract key findings, datasets, and comparative methods across publications.
Benchmark Rankings & Visual Analytics
Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.
Connect Distant Disciplines
Bridge topological clusters on the map to find hidden collaborative intersections.
Prevention of Adverse Cardiovascular Events Using the 23-Valent Pneumococcal Polysaccharide Vaccine — Shu Ren, David N Dürrheim, et al. · JAMA Cardiology (2025) | TGRS Research Map | TGRS